Kinnate Biopharma Insider Trades

KNTE

Track insider trading activity from Kinnate Biopharma executives and directors. See which insiders are buying and selling KNTE stock.

Trades Last 12 Months

KNTE Price

All Insider Trades for Kinnate Biopharma

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
De Simone Jill Director
Holding Value $0 0 shares
Last Trade
Apr 03, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$133k 50,000 shares
$2.65
$2.65
Holding Value $0 0 shares
Last Trade
Apr 03, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$335k 126,251 shares
$2.65
$2.65
Farzan Nima CHIEF EXECUTIVE OFFICER
Holding Value $0 0 shares
Last Trade
Apr 03, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$8.34M 3,146,241 shares
$2.65
$2.65
Holding Value $0 0 shares
Last Trade
Apr 03, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$613k 231,444 shares
$2.65
$2.65
Holding Value $0 0 shares
Last Trade
Apr 03, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.35M 520,711 shares
$2.59
$2.65
Gordon Carl L 10% owner
Holding Value $0 0 shares
Last Trade
Apr 03, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$66.3k 25,000 shares
$2.65
$2.65
Sabzevari Helen Director
Holding Value $0 0 shares
Last Trade
Apr 03, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$227k 85,751 shares
$2.65
$2.65
Holding Value $0 0 shares
Last Trade
Apr 03, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$335k 126,251 shares
$2.65
$2.65
Tananbaum James B. 10% owner
Holding Value $0 0 shares
Last Trade
Apr 03, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.54M 581,462 shares
$2.65
$2.65
Krishnamohan Neha CHIEF FINANCIAL OFFICER
Holding Value $0 0 shares
Last Trade
Apr 03, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.95M 734,087 shares
$2.65
$2.65
Meltz Mark A COO GENERAL COUNSEL SECRETARY
Holding Value $0 0 shares
Last Trade
Apr 03, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$2.61M 983,589 shares
$2.65
$2.65
Mitchell Dean J Director
Holding Value $0 0 shares
Last Trade
Apr 03, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$376k 141,753 shares
$2.65
$2.65
Holding Value $0 0 shares
Last Trade
Apr 03, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.17M 450,000 shares
$2.59
$2.65
Rome Michael E Director
Holding Value $0 0 shares
Last Trade
Apr 03, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$161k 60,751 shares
$2.65
$2.65
Williams Richard Thomas CHIEF MEDICAL OFFICER
Holding Value $179k 67,588 shares
Last Trade
Mar 01, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.45k 558 shares
$2.59
$2.65
Murphy Eric Anthony Chief Scientific Officer
Holding Value $159k 60,000 shares
Last Trade
Feb 12, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.12M 60,000 shares
$35.38
$2.65
Kaldor Stephen W Director
Holding Value $4.28M 1,615,826 shares
Last Trade
Dec 02, 2020 Sale
No data
No data
$2.65

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up